Immatics Sees Revenue Surge Despite R&D Expenses

Immatics (IMTX) has released an update.

Immatics reported a significant increase in collaboration revenue for the nine months ending September 30, 2024, reaching €99.6 million compared to €38.1 million in the same period last year. Despite higher revenue, the company faced substantial research and development expenses, which contributed to a loss before taxes of €2.4 million for Q3 2024. Investors should note the company’s ongoing focus on R&D, which may impact financial performance in the near term.

For further insights into IMTX stock, check out TipRanks’ Stock Analysis page.